C

CAPELLETTO E.

Last name: CAPELLETTO E.

2018 (v1)

Publication

Metadata-only

NGR-hTNF and Doxorubicin as Second-Line Treatment of Patients with Small Cell Lung Cancer

Gregorc V. Cavina R. Novello S.

Lessons Learned: NGR-hTNF was safely combined with doxorubicin, showing a promising antitumor activity in unselected patients with relapsed small cell lung cancer. Similar antitumor activity was observed in platinum-sensitive and platinum-resistant patient cohorts. Background: Relapsed small cell lung cancer (SCLC) patients have limited...

Uploaded on: April 14, 2023
2022 (v1)

Publication

Metadata-only

A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma

Tagliamento M. Bironzo P. Curcio H.

Introduction: Advanced stage malignant mesothelioma (asMM) patients have poor prognosis. Several trials investigated the role of programmed cell death protein-1 (PD-1) and its ligand 1 (PD-L1) immune checkpoint inhibitors (ICIs) in pre-treated asMM. Methods: A systematic review of the literature of clinical trials testing single-agent anti...

Uploaded on: February 11, 2024